Pathogenic variants in MAGUKs (DLG4/PSD-95, CASK, etc.)have been reported in patients with DEE.20 Thus, the significance of the LGI1–ADAM22/23–MAGUK pathway in human brain functions and diseases remains unclear. This evidence concerns the gene ADAM22 and developmental and epileptic encephalopathy.